Nadira Delhem

Inserm

Papers

1

Total Citations

29

H-Index

1

About

Dr. Nadira Delhem is a leading neuro-oncology researcher whose work focuses on developing innovative treatments for glioblastoma (GBM), the most aggressive form of brain cancer. Her major contribution lies in advancing interstitial photodynamic therapy (iPDT) as a standardized, clinically viable procedure for patients with inoperable or recurrent GBMs. Her landmark 2021 paper, which has garnered 29 citations, provides a rigorous protocol for iPDT, demonstrating how light-activated agents can precisely target residual tumor cells after surgery, offering new hope for patients with a median survival of just 15 months under current standard care. This work is notable for bridging the gap between experimental photodynamic therapy and practical clinical application, addressing a critical unmet need for patients harboring deep-seated or diffuse tumors. Dr. Delhem’s research has been instrumental in reshaping treatment paradigms for high-grade gliomas, and her standardized approach is now being adopted in multiple clinical centers. Her dedication to translating complex biophotonic science into tangible patient benefits marks her as a rising authority in the fight against brain cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
29
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Interstitial Photodynamic Therapy for Glioblastomas: A Standardized Procedure for Clinical Use
29 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Inserm

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago